Brain Structure and Function

, Volume 223, Issue 7, pp 3317–3326 | Cite as

Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks

  • Francesca M. FilbeyEmail author
  • Suril Gohel
  • Shikha Prashad
  • Bharat B. Biswal
Original Article


Concomitant cannabis and nicotine use is more prevalent than cannabis use alone; however, to date, most of the literature has focused on associations of isolated cannabis and nicotine use limiting the generalizability of existing research. To determine differential associations of concomitant use of cannabis and nicotine, isolated cannabis use and isolated nicotine use on brain network connectivity, we examined systems-level neural functioning via independent components analysis (ICA) on resting state networks (RSNs) in cannabis users (CAN, n = 53), nicotine users (NIC, n = 28), concomitant nicotine and cannabis users (NIC + CAN, n = 26), and non-users (CTRL, n = 30). Our results indicated that the CTRL group and NIC + CAN users had the greatest functional connectivity relative to CAN users and NIC users in 12 RSNs: anterior default mode network (DMN), posterior DMN, left frontal parietal network, lingual gyrus, salience network, right frontal parietal network, higher visual network, insular cortex, cuneus/precuneus, posterior cingulate gyrus/middle temporal gyrus, dorsal attention network, and basal ganglia network. Post hoc tests showed no significant differences between (1) CTRL and NIC + CAN and (2) NIC and CAN users. These findings of differential associations of isolated vs. combined nicotine and cannabis use demonstrate an interaction between cannabis and nicotine use on RSNs. These unique and combined mechanisms through which cannabis and nicotine influence cortical network functional connectivity are important to consider when evaluating the neurobiological pathways associated with cannabis and nicotine use.


Addiction Cannabis Nicotine Resting state fMRI Functional connectivity Independent component analysis 



This study was funded by the National Institutes of Health (grants K01 DA021632, R01DA030344-01A1, and R01 DA038895).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Agrawal A, Lynskey MT (2009) Tobacco and cannabis co-occurrence: does route of administration matter? Drug Alcohol Depend 99:240–247. CrossRefPubMedGoogle Scholar
  2. Agrawal A, Budney AJ, Lynskey MT (2012) The co-occurring use and misuse of cannabis and tobacco: a review: cannabis and tobacco review. Addiction 107:1221–1233. CrossRefPubMedPubMedCentralGoogle Scholar
  3. Amos A, Wiltshire S, Bostock Y et al (2004) ‘You can’t go without a fag… you need it for your hash’—a qualitative exploration of smoking, cannabis and young people. Addiction 99:77–81CrossRefPubMedGoogle Scholar
  4. Birn RM, Molloy EK, Patriat R et al (2013) The effect of scan length on the reliability of resting-state fMRI connectivity estimates. NeuroImage 83:550–558. CrossRefPubMedPubMedCentralGoogle Scholar
  5. Biswal BB, Kylen JV, Hyde JS (1997) Simultaneous assessment of flow and BOLD signals in resting-state functional connectivity maps. NMR Biomed 10:165–170CrossRefPubMedGoogle Scholar
  6. Biswal BB, Mennes M, Zuo X-N et al (2010) Toward discovery science of human brain function. Proc Natl Acad Sci 107:4734–4739. CrossRefPubMedGoogle Scholar
  7. Bonn-Miller MO, Zvolensky MJ, Johnson KA (2010) Uni-morbid and co-occurring marijuana and tobacco wue: examination of concurrent associations with negative mood states. J Addict Dis 29:68–77CrossRefPubMedPubMedCentralGoogle Scholar
  8. Brody AL, Mandelkern MA, Jarvik ME et al (2004) Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry 55:77–84. CrossRefPubMedGoogle Scholar
  9. Cahill K, Ussher MH (2011) Cannabinoid type 1 receptor antagonists for smoking cessation. Cochrane Database Syst Rev 3:Art. No.: CD005353.
  10. Chang L (2006) Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129:1096–1112. CrossRefPubMedGoogle Scholar
  11. Claus ED, Blaine SK, Filbey FM et al (2013) Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology 38:2363–2372CrossRefPubMedPubMedCentralGoogle Scholar
  12. Cohen C, Perrault G, Voltz C et al (2002) SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463CrossRefPubMedGoogle Scholar
  13. Cousijn J, Wiers RW, Ridderinkhof KR et al (2012) Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. NeuroImage 59:3845–3851. CrossRefPubMedGoogle Scholar
  14. Cousijn J, Vingerhoets WAM, Koenders L et al (2014) Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls: Working-memory and substance use. Addict Biol 19:282–293. CrossRefPubMedGoogle Scholar
  15. Fagerstrom K-O, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159–182CrossRefPubMedGoogle Scholar
  16. Filbey FM, Yezhuvath U (2013) Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am J Drug Alcohol Abuse 39:382–391. CrossRefPubMedPubMedCentralGoogle Scholar
  17. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE (2009) Marijuana craving in the brain. Proc Natl Acad Sci USA 106(31):13016–13021. CrossRefPubMedGoogle Scholar
  18. Filbey FM, Aslan S, Calhoun VD et al (2014) Long-term effects of marijuana use on the brain. Proc Natl Acad Sci 111:16913–16918. CrossRefPubMedGoogle Scholar
  19. Filbey FM, McQueeny T, Kadamangudi S et al (2015) Combined effects of marijuana and nicotine on memory performance and hippocampal volume. Behav Brain Res 293:46–53. CrossRefPubMedPubMedCentralGoogle Scholar
  20. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New YorkGoogle Scholar
  21. Forget B, Hamon M, Thiébot M-H (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology 181:722–734. CrossRefPubMedGoogle Scholar
  22. Gamaleddin I, Wertheim C, Zhu AZX et al (2012) Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking: Cannabinoid receptors and nicotine. Addict Biol 17:47–61. CrossRefPubMedGoogle Scholar
  23. Gfroerer JC, Greenblatt JC, Wright DA (1997) Substance use in the US college-age population: differences according to educational status and living arrangement. Am J Public Health 87:62–65CrossRefPubMedPubMedCentralGoogle Scholar
  24. Gilman JM, Kuster JK, Lee S et al (2014) Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci 34:5529–5538. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Hahn B, Ross TJ, Yang Y et al (2007) Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. J Neurosci 27:3477–3489. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 17:825–841. CrossRefPubMedGoogle Scholar
  27. Karoly HC, Bryan AD, Weiland BJ et al (2015) Does incentive-elicited nucleus accumbens activation differ by substance of abuse? An examination with adolescents. Dev Cogn Neurosci 16:5–15. CrossRefPubMedPubMedCentralGoogle Scholar
  28. Le Foll B (2004) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312:875–883. CrossRefPubMedGoogle Scholar
  29. Leroy C, Karila L, Martinot J-L et al (2012) Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study: DAT availability in addictions. Addict Biol 17:981–990. CrossRefPubMedGoogle Scholar
  30. Liao Y, Tang J, Liu T et al (2012) Differences between smokers and non-smokers in regional gray matter volumes: a voxel-based morphometry study: gray matter changes in smokers. Addict Biol 17:977–980. CrossRefPubMedGoogle Scholar
  31. Panlilio LV, Solinas M, Matthews SA, Goldberg SR (2007) Previous exposure to THC alters the reinforcing efficacy and anxiety-related effects of cocaine in rats. Neuropsychopharmacology 32:646–657CrossRefPubMedGoogle Scholar
  32. Poorthuis RB, Goriounova NA, Couey JJ, Mansvelder HD (2009) Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Biochem Pharmacol 78:668–676. CrossRefPubMedGoogle Scholar
  33. Pujol J, Blanco-Hinojo L, Batalla A et al (2014) Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users. J Psychiatr Res 51:68–78. CrossRefPubMedGoogle Scholar
  34. Raichle ME, MacLeod AM, Snyder AZ et al (2001) A default mode of brain function. Proc Natl Acad Sci 98:676–682CrossRefPubMedGoogle Scholar
  35. Rigotti NA, Gonzales D, Dale LC et al (2009) A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain. Addiction 104:266–276. CrossRefPubMedGoogle Scholar
  36. Schuster RM, Crane NA, Mermelstein R, Gonzalez R (2015) Tobacco may mask poorer episodic memory among young adult cannabis users. Neuropsychology 29:759–766. CrossRefPubMedPubMedCentralGoogle Scholar
  37. Seeley WW, Menon V, Schatzberg AF et al (2007) Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 27:2349–2356. CrossRefPubMedPubMedCentralGoogle Scholar
  38. Shoaib M (2008) The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology 54:438–444. CrossRefPubMedGoogle Scholar
  39. Sobell LC, Sobell MB (1992) Timeline Follow-Back. In: Litten RZ, Allen JP (eds) Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press, Totowa, pp 41–72CrossRefGoogle Scholar
  40. Subramaniam P, McGlade E, Yurgelun-Todd D (2016) Comorbid cannabis and tobacco use in adolescents and adults. Curr Addict Rep 3:182–188. CrossRefPubMedPubMedCentralGoogle Scholar
  41. Substance Abuse and Mental Health Services Administration (2014) Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration, RockvilleGoogle Scholar
  42. Sutherland MT, McHugh MJ, Pariyadath V, Stein EA (2012) Resting state functional connectivity in addiction: lessons learned and a road ahead. NeuroImage 62:2281–2295. CrossRefPubMedPubMedCentralGoogle Scholar
  43. Tanabe J, Nyberg E, Martin LF et al (2011) Nicotine effects on default mode network during resting state. Psychopharmacology 216:287–295. CrossRefPubMedPubMedCentralGoogle Scholar
  44. Taylor PA, Saad ZS (2013) FATCAT: (an efficient) functional and tractographic connectivity analysis toolbox. Brain Connect 3:523–535. CrossRefPubMedPubMedCentralGoogle Scholar
  45. Taylor PA, Gohel S, Di X et al (2012) Functional covariance networks: obtaining resting-state networks from intersubject variability. Brain Connect 2:203–217CrossRefPubMedPubMedCentralGoogle Scholar
  46. Turner JA, Damaraju E, van Erp TGM et al (2013) A multi-site resting state fMRI study on the amplitude of low frequency fluctuations in schizophrenia. Front Neurosci 7:.
  47. Valjent E, Mitchell JM, Besson M-J et al (2002) Behavioural and biochemical evidence for interactions between ∆9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564–578CrossRefPubMedPubMedCentralGoogle Scholar
  48. Van Dijk KRA, Hedden T, Venkataraman A et al (2010) intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol 103:297–321. CrossRefPubMedGoogle Scholar
  49. Vergara VM, Weiland BJ, Hutchison KE, Calhoun VD (2018) The impact of combinations of alcohol, nicotine, and cannabis on dynamic brain connectivity. Neuropsychopharmacology 43:877–890. CrossRefPubMedGoogle Scholar
  50. Viveros M, Marco E, File S (2006) Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci Biobehav Rev 30:1161–1181. CrossRefPubMedGoogle Scholar
  51. Weiland BJ, Sabbineni A, Calhoun VD et al (2015) Reduced executive and default network functional connectivity in cigarette smokers. Hum Brain Mapp 36:872–882. CrossRefPubMedGoogle Scholar
  52. Wetherill RR, Fang Z, Jagannathan K et al (2015) Cannabis, cigarettes, and their co-occurring use: Disentangling differences in default mode network functional connectivity. Drug Alcohol Depend 153:116–123. CrossRefPubMedPubMedCentralGoogle Scholar
  53. Yu R, Zhao L, Lu L (2011) Regional grey and white matter changes in heavy male smokers. PLoS One 6:e27440. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Francesca M. Filbey
    • 1
    Email author
  • Suril Gohel
    • 3
  • Shikha Prashad
    • 1
  • Bharat B. Biswal
    • 2
  1. 1.Center for BrainHealth, School of Behavioral and Brain SciencesUniversity of Texas at DallasDallasUSA
  2. 2.Department of Biomedical EngineeringNew Jersey Institute of TechnologyNewarkUSA
  3. 3.Department of Health Informatics, School of Health ProfessionsRutgers UniversityNewarkUSA

Personalised recommendations